Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells

被引:384
作者
Duluc, Dorothee [1 ,10 ]
Delneste, Yves [1 ,10 ]
Tan, Fang [1 ,10 ]
Moles, Marie-Pierre [1 ,2 ,3 ,10 ]
Grimaud, Linda
Lenoir, Julien [1 ,2 ]
Preisser, Laurence
Anegon, Ignacio [4 ,5 ]
Catala, Laurent [6 ]
Ifrah, Norbert [2 ,3 ]
Descamps, Philippe [6 ]
Gamelin, Erick [1 ,7 ]
Gascan, Hugues [1 ]
Hebbar, Mohamed [8 ]
Jeannin, Pascale [1 ,9 ,10 ]
机构
[1] Univ Angers, Unite Rech Sante 564, Angers, France
[2] UPRES EA3863, Angers, France
[3] CHU Angers, Dept Malad Sang, Angers, France
[4] INSERM, UMR 643, Nantes, France
[5] Univ Nantes, Inst Transplantat & Rech Transplantat, FOCIS, Nantes, France
[6] CHU Angers, Dept Gynecol, Angers, France
[7] Ctr Lutte Contre Canc Paul Papin, Angers, France
[8] CHU Lille, Dept Oncol, F-59037 Lille, France
[9] CHU Angers, Lab Immunol & Allergol, Angers, France
[10] Ctr Hosp Univ, INSERM, Unit Equipe Avenir 564, F-49933 Angers, France
关键词
D O I
10.1182/blood-2007-02-072587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-associated macrophages (TAMs), the most abundant immunosuppressive cells in the tumor microenvironment, originate from blood monocytes and exhibit an IL-10(high)IL-12(low) M2 profile. The factors involved in TAM generation remain unidentified. We identify here leukemia inhibitory factor (LIF) and IL-6 as tumor microenvironmental factors that can promote TAM generation. Ovarian cancer ascites switched monocyte differentiation into TAM-like cells that exhibit most ovarian TAM functional and phenotypic characteristics. Ovarian cancer ascites contained high concentrations of LIF and IL-6. Recombinant LIF and IL-6 skew monocyte differentiation into TAM-like cells by enabling monocytes to consume monocyte-colony-stimulating factor (M-CSF). Depletion of LIF, IL-6, and M-CSF in ovarian cancer ascites suppressed TAM-like cell induction. We extended these observations to different tumor-cell line supernatants. In addition to revealing a new tumor-escape mechanism associated with TAM generation via LIF and IL-6, these findings offer novel therapeutic perspectives to subvert TAM-induced immunosuppression and hence improve T-cell-based antitumor immunotherapy efficacy.
引用
收藏
页码:4319 / 4330
页数:12
相关论文
共 68 条
  • [1] Allavena P, 1997, ADV EXP MED BIOL, V417, P323
  • [2] Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
    Almand, B
    Clark, JI
    Nikitina, E
    van Beynen, J
    English, NR
    Knight, SC
    Carbone, DP
    Gabrilovich, DI
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 678 - 689
  • [3] Bernard C, 1999, CIRC RES, V85, P1124
  • [4] A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
    Biswas, SK
    Gangi, L
    Paul, S
    Schioppa, T
    Saccani, A
    Sironi, M
    Bottazzi, B
    Doni, A
    Vincenzo, B
    Pasqualini, F
    Vago, L
    Nebuloni, M
    Mantovani, A
    Sica, A
    [J]. BLOOD, 2006, 107 (05) : 2112 - 2122
  • [5] LEUKEMIA INHIBITORY FACTOR DERIVED FROM RAT COLON-CARCINOMA CELLS INCREASES HOST SUSCEPTIBILITY TO TUMOR-GROWTH
    BURG, C
    PATRY, Y
    LEPENDU, J
    MOREAU, M
    TESSON, L
    GODARD, A
    SOUILLOU, JP
    MEFLAH, K
    ANEGON, I
    [J]. CYTOKINE, 1995, 7 (08) : 784 - 792
  • [6] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [7] Tolerization of dendritic cells by TS cells:: the crucial role of inhibitory receptors ILT3 and ILT4
    Chang, CC
    Ciubotariu, R
    Manavalan, JS
    Yuan, J
    Colovai, AI
    Piazza, F
    Lederman, S
    Colonna, M
    Cortesini, R
    Dalla-Favera, R
    Suciu-Foca, N
    [J]. NATURE IMMUNOLOGY, 2002, 3 (03) : 237 - 243
  • [8] Oncostatin M: a pleiotropic cytokine in the central nervous system
    Chen, SH
    Benveniste, EN
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (05) : 379 - 391
  • [9] IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
    Chomarat, P
    Banchereau, J
    Davoust, J
    Palucka, AK
    [J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 510 - 514
  • [10] Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion
    Colombo, MP
    Mantovani, A
    [J]. CANCER RESEARCH, 2005, 65 (20) : 9113 - 9116